1. Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study
- Author
-
Yan Du, Xu Liu, Juan Li, Ru Li, Fanlei Hu, Huanfa Yi, Yuan Jia, Zhanguo Li, Shixian Chen, Wei Zhang, Xi Zheng, Daming Zuo, Hua Ye, Xiaoying Zhang, Yingni Li, Fang Xiangyu, Jiang Xiang, Jimeng Xue, Limin Ren, Liang Liu, Mingxin Bai, Jianping Guo, Xiang-Yang Wang, Yongfu Wang, Yang Xie, Hudan Pan, Fei Huang, Chunqing Guo, Yin Su, Huaxiang Wu, Xin Li, Jing Song, and Ping Wang
- Subjects
0301 basic medicine ,Oncology ,Male ,medicine.medical_specialty ,Science ,General Physics and Astronomy ,Arthritis ,02 engineering and technology ,Disease ,Sensitivity and Specificity ,General Biochemistry, Genetics and Molecular Biology ,Article ,Arthritis, Rheumatoid ,03 medical and health sciences ,Mice ,Rheumatoid Factor ,Internal medicine ,medicine ,Rheumatoid factor ,Animals ,Humans ,Scavenger receptor ,Stage (cooking) ,Rheumatoid arthritis ,lcsh:Science ,Mice, Knockout ,Multidisciplinary ,Effector ,business.industry ,food and beverages ,Scavenger Receptors, Class A ,Diagnostic markers ,General Chemistry ,021001 nanoscience & nanotechnology ,medicine.disease ,Mice, Inbred C57BL ,Disease Models, Animal ,030104 developmental biology ,Biomarker (medicine) ,lcsh:Q ,0210 nano-technology ,business ,Biomarkers - Abstract
Early diagnosis is critical to improve outcomes in rheumatoid arthritis (RA), but current diagnostic tools have limited sensitivity. Here we report a large-scale multicenter study involving training and validation cohorts of 3,262 participants. We show that serum levels of soluble scavenger receptor-A (sSR-A) are increased in patients with RA and correlate positively with clinical and immunological features of the disease. This discriminatory capacity of sSR-A is clinically valuable and complements the diagnosis for early stage and seronegative RA. sSR-A also has 15.97% prevalence in undifferentiated arthritis patients. Furthermore, administration of SR-A accelerates the onset of experimental arthritis in mice, whereas inhibition of SR-A ameliorates the disease pathogenesis. Together, these data identify sSR-A as a potential biomarker in diagnosis of RA, and targeting SR-A might be a therapeutic strategy., Scavenger receptor-A (SR-A) is mostly expressed by myeloid cells and has been attributed a variety of biological functions. Here the authors assess SR-A as a biomarker for diagnosis of rheumatoid arthritis (RA) using large-scale training and validation cohorts and show that modulating SR-A levels can alter progression of collagen-induced arthritis in mice.
- Published
- 2020